The FNTB promoter polymorphism rs11623866 as a potential predictive biomarker for lonafarnib treatment of ovarian cancer patients.
about
The FNTB promoter polymorphism rs11623866 as a potential predictive biomarker for lonafarnib treatment of ovarian cancer patients.
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
The FNTB promoter polymorphism ...... nt of ovarian cancer patients.
@ast
The FNTB promoter polymorphism ...... nt of ovarian cancer patients.
@en
The FNTB promoter polymorphism ...... nt of ovarian cancer patients.
@nl
type
label
The FNTB promoter polymorphism ...... nt of ovarian cancer patients.
@ast
The FNTB promoter polymorphism ...... nt of ovarian cancer patients.
@en
The FNTB promoter polymorphism ...... nt of ovarian cancer patients.
@nl
altLabel
The FNTB promoter polymorphism ...... ent of ovarian cancer patients
@en
prefLabel
The FNTB promoter polymorphism ...... nt of ovarian cancer patients.
@ast
The FNTB promoter polymorphism ...... nt of ovarian cancer patients.
@en
The FNTB promoter polymorphism ...... nt of ovarian cancer patients.
@nl
P2093
P2860
P50
P921
P356
P1476
The FNTB promoter polymorphism ...... nt of ovarian cancer patients.
@en
P2093
Alexander Burges
Andreas du Bois
Barbara Schmalfeldt
Behnaz Aminossadati
Hagen Sjard Bachmann
Kerstin Wollschlaeger
Peter Hillemanns
Rainer Kimmig
Werner Meier
Winfried Siffert
P2860
P304
P356
10.1111/BCP.12688
P407
P577
2015-11-01T00:00:00Z